多模态免疫组库分析揭示免疫介导疾病中的B细胞生物学特征
研究对595名免疫介导疾病患者及健康供者的5个B细胞亚群进行B细胞受体组库分析,发现自身免疫病患者初始B细胞CDR-H3缩短且与干扰素特征负相关,SLE患者浆母细胞和未转换记忆B细胞存在V(D)J基因使用偏斜并与疾病活动相关,贝利尤单抗治疗后偏斜改善。
要点
- 自身免疫病患者初始B细胞CDR-H3长度缩短,且与干扰素特征强度呈强负相关。
- SLE患者浆母细胞和未转换记忆B细胞V(D)J基因使用偏斜,偏斜评分与外周辅助T细胞特征正相关、与浆母细胞体细胞高频突变负相关。
- 未转换记忆B细胞IGHV4-34基因使用偏高,与SLE疾病活动度正相关,贝利尤单抗治疗后改善。
核心结论
- 多模态组库分析实现了对免疫介导疾病中B细胞异常的系统层面理解。
研究设计与样本
- 研究纳入595名免疫介导疾病患者及健康供者,对分选B细胞亚群的RNA测序数据绘制B细胞受体区域。
- 研究分析5个B细胞亚群的组库特征,包括与免疫细胞转录组和临床特征的关联及对贝利尤单抗治疗的反应。
主要发现
- 自身免疫病患者初始B细胞中重链互补决定区3(CDR-H3)长度缩短。
- 初始B细胞中干扰素特征强度与CDR-H3长度呈强负相关,提示干扰素在B细胞过早发育中的作用。
- SLE患者浆母细胞和未转换记忆B细胞中V(D)J基因使用偏斜。
- 偏斜评分与外周辅助T细胞转录组特征正相关,与浆母细胞体细胞高频突变数量负相关,提示与滤泡外途径的关联。
- 未转换记忆B细胞中IGHV4-34基因及9G4独特型使用偏高,与SLE疾病活动度呈显著正相关,贝利尤单抗治疗后未转换记忆B细胞基因使用偏斜改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite the involvement of B cells in the pathogenesis of immune-mediated diseases (IMDs), biological mechanisms underlying their function are scarcely understood. To overcome this gap, here we constructed and investigated a large-scale repertoire catalogue of five B cell subsets of patients with IMDs. METHODS: We mapped B cell receptor regions from RNA sequencing data of sorted B cell subsets. Our dataset consisted of 595 donors under IMDs and health. We characterised the repertoire features from various aspects, including their association with immune cell transcriptomes and clinical features and their response to belimumab treatment. RESULTS: Heavy-chain complementarity-determining region 3 (CDR-H3) length among naïve B cells was shortened among autoimmune diseases. Strong negative correlation between interferon signature strength and CDR-H3 length was observed in naïve B cells and suggested the role for interferon in premature B cell development. VDJ gene usage was skewed especially in plasmablasts and unswitched-memory B cells of patients with systemic lupus erythematosus (SLE). We developed a scoring system to quantify this skewing, and it positively correlated with peripheral helper T cell transcriptomic signatures and negatively correlated with the amount of somatic hyper mutations in plasmablasts, suggesting the association of extrafollicular pathway. Further, this skewing led to high usage of IGHV4-34 gene with 9G4 idiotypes in unswitched-memory B cells, which showed a prominent positive correlation with disease activity in SLE. Gene usage skewing in unswitched-memory B cells was ameliorated after belimumab treatment. CONCLUSIONS: Our multimodal repertoire analysis enabled us the system-level understanding of B cell abnormality in diseases.
引用
- Ota M, Nakano M, Nagafuchi Y, et al. Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases. Ann Rheum Dis. 2023. PMID: 37468219. doi:10.1136/ard-2023-224421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。